The DOI matches its Crossref record.
Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast Cancer
Open accessAbstract
Purpose: Drug resistance and metastasis pose major impediments in the successful treatment of cancer. We previously reported that multidrug-resistant breast cancer cells exhibit high levels of tissue transglutaminase (TG2; EC 2.3.2.13). Because the drug-resistant and metastatic phenotypes are thought to share some common pathways, we sought to determine whether metastatic breast cancer cells express high levels of TG2. Experimental Design: The metastatic breast cancer cell line MDA-MB-231 and the sublines derived from it were tested for TG2 expression. Similarly, several sublines derived from an immortal but normal breast epithelial cell line, MCF10A, representing various stages in breast cancer progression were studied for TG2 expression. The primary and nodal tumor samples from 30 patients with breast cancer were also studied for TG2 expression. Results: The MDA-MB-231 cells expressed high basal levels of TG2. Two clones derived from this cell line, MDA231/cl.9 and MDA231/cl.16, showed a 10- to 15-fold difference in TG2 level. TG2-deficient MDA231/cl.9 cells exhibited higher sensitivity to doxorubicin and were less invasive than were the TG2-sufficient MDA231/cl.16 cells. The MCF10A-derived sublines had increased TG2 expression as they advanced from noninvasive to an invasive phenotype. Importantly, the metastatic lymph node tumors from patients with breast cancer showed significant higher levels of TG2 expression compared with the primary tumors from the same patients. Conclusions: TG2 expression is up-regulated in drug-resistant and metastatic breast cancer cells, and it can serve as a valuable prognostic marker for these phenotypes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Concepts of extracellular matrix remodelling in tumour progression and metastasis
Winkler, J., Abisoye-Ogunniyan, A., Metcalf, K. J., & Werb, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-18794-x · Cited by 2,296
Dalby, K., Tekedereli, I., Lopez-Berestein, G., & Ozpolat, B. (2010) · Autophagy · doi:10.4161/auto.6.3.11625 · Cited by 446
Transglutaminase Regulation of Cell Function
Eckert, R. L., Kaartinen, M. T., Nurminskaya, M., Belkin, A. M., Colak, G., Johnson, G. V. W., & Mehta, K. (2014) · Physiological Reviews · doi:10.1152/physrev.00019.2013 · Cited by 419
Self-citationCellular Traction Stresses Increase with Increasing Metastatic Potential
Kraning-Rush, C. M., Califano, J. P., & Reinhart-King, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032572 · Cited by 400
Evangelisti, C., Florian, M. C., Massimi, I., Dominici, C., Giannini, G., Galardi, S., Buè, M. C., Massalini, S., McDowell, H. P., Messi, E., et al. (2009) · The FASEB Journal · doi:10.1096/fj.09-134965 · Cited by 140
Metadata
- Authors
- Mehta, K., Fok, J., Miller, F. R., Koul, D., & Sahin, A. A.
- Venue
- Clinical Cancer Research
- Published
- 2004-12-01
- Volume
- 10
- Issue
- 23
- Pages
- 8068-8076
- ISSN
- 1078-0432 (ISSN-L)
- 1557-3265
- OpenAlex
- W2100545793
- Cited by
- 183
- References
- 0
- FWCI
- 3.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-04-1107
- The paper
- Mehta, K., Fok, J., Miller, F. R., Koul, D., & Sahin, A. A. (2004). Prognostic Significance of Tissue Transglutaminase in Drug Resistant and Metastatic Breast Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-04-1107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.